$DHI
HORTON D R INC /DE/

2024 Q3 Form 10-Q Financial Statement

#000088218424000039 Filed on July 23, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $10.00B $9.966B
YoY Change -4.77% 2.47%
Cost Of Revenue $7.448B $7.324B
YoY Change -2.54% 2.68%
Gross Profit $2.554B $2.642B
YoY Change -10.74% 1.9%
Gross Profit Margin 25.54% 26.51%
Selling, General & Admin $960.2M $923.6M
YoY Change 8.47% 8.51%
% of Gross Profit 37.59% 34.96%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $23.60M $22.40M
YoY Change 10.28% -5.49%
% of Gross Profit 0.92% 0.85%
Operating Expenses $844.6M $843.0M
YoY Change 7.1% 7.21%
Operating Profit $1.710B $1.799B
YoY Change -17.53% -0.42%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $80.60M
YoY Change 54.41%
Pretax Income $1.710B $1.799B
YoY Change -15.29% 0.85%
Income Tax $409.9M $432.2M
% Of Pretax Income 23.97% 24.02%
Net Earnings $1.283B $1.354B
YoY Change -14.99% 1.39%
Net Earnings / Revenue 12.83% 13.58%
Basic Earnings Per Share $4.12
Diluted Earnings Per Share $3.92 $4.10
COMMON SHARES
Basic Shares Outstanding 326.0M shares 329.3M shares
Diluted Shares Outstanding 330.1M shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.516B $2.992B
YoY Change 16.59% -11.45%
Cash & Equivalents $4.516B $2.992B
Short-Term Investments
Other Short-Term Assets $117.9M $96.30M
YoY Change 26.77% 65.75%
Inventory $24.90B $25.54B
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $29.42B $28.53B
YoY Change 10.3% 6.7%
LONG-TERM ASSETS
Property, Plant & Equipment $531.0M $520.9M
YoY Change 19.22% 10.9%
Goodwill $163.5M $163.5M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $195.1M $184.3M
YoY Change -8.7% -14.91%
Total Long-Term Assets $6.685B $6.623B
YoY Change 13.12% 18.55%
TOTAL ASSETS
Total Short-Term Assets $29.42B $28.53B
Total Long-Term Assets $6.685B $6.623B
Total Assets $36.10B $35.15B
YoY Change 10.81% 8.75%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.346B $1.413B
YoY Change 7.97% 3.15%
Accrued Expenses $3.017B $2.897B
YoY Change 23.6% 28.82%
Deferred Revenue
YoY Change
Short-Term Debt $1.534B $1.691B
YoY Change -8.13% 0.34%
Long-Term Debt Due $633.6M $400.0K
YoY Change 233.47% -99.93%
Total Short-Term Liabilities $4.362B $4.310B
YoY Change -26.41% -29.8%
LONG-TERM LIABILITIES
Long-Term Debt $5.918B $5.691B
YoY Change 82.93% 46.63%
Other Long-Term Liabilities $186.2M $148.8M
YoY Change -34.02% -32.49%
Total Long-Term Liabilities $5.918B $5.691B
YoY Change 68.26% 38.75%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.362B $4.310B
Total Long-Term Liabilities $5.918B $5.691B
Total Liabilities $10.79B $10.49B
YoY Change 14.26% -1.61%
SHAREHOLDERS EQUITY
Retained Earnings $27.95B $26.77B
YoY Change 18.49% 20.76%
Common Stock $3.495B $3.463B
YoY Change 1.7% 1.89%
Preferred Stock
YoY Change
Treasury Stock (at cost) $6.133B $5.572B
YoY Change 41.64% 42.62%
Treasury Stock Shares
Shareholders Equity $25.31B $24.66B
YoY Change
Total Liabilities & Shareholders Equity $36.10B $35.15B
YoY Change 10.81% 8.75%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income $1.283B $1.354B
YoY Change -14.99% 1.39%
Depreciation, Depletion And Amortization $23.60M $22.40M
YoY Change 10.28% -5.49%
Cash From Operating Activities $1.962B $698.3M
YoY Change -3.98% -11.33%
INVESTING ACTIVITIES
Capital Expenditures $32.00M $62.00M
YoY Change -20.6% 113.06%
Acquisitions
YoY Change
Other Investing Activities $2.500M -$33.10M
YoY Change -93.52% -66.5%
Cash From Investing Activities -$29.50M -$95.10M
YoY Change 1635.29% -25.65%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -408.1M -676.6M
YoY Change -73.66% 107.42%
NET CHANGE
Cash From Operating Activities 1.962B 698.3M
Cash From Investing Activities -29.50M -95.10M
Cash From Financing Activities -408.1M -676.6M
Net Change In Cash 1.524B -73.40M
YoY Change 209.69% -122.02%
FREE CASH FLOW
Cash From Operating Activities $1.962B $698.3M
Capital Expenditures $32.00M $62.00M
Free Cash Flow $1.930B $636.3M
YoY Change -3.65% -16.1%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0000882184
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
445400000 usd
CY2024Q2 us-gaap Other Assets
OtherAssets
3175500000 usd
CY2023Q3 us-gaap Other Assets
OtherAssets
2993000000 usd
CY2024Q2 us-gaap Goodwill
Goodwill
163500000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
163500000 usd
CY2024Q2 us-gaap Assets
Assets
35151400000 usd
CY2023Q3 us-gaap Assets
Assets
32582400000 usd
CY2024Q2 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
1412700000 usd
CY2023Q3 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
1246200000 usd
CY2024Q2 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
2897000000 usd
CY2023Q3 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
3103800000 usd
CY2024Q2 us-gaap Notes Payable
NotesPayable
5691000000 usd
CY2023Q3 us-gaap Notes Payable
NotesPayable
5094500000 usd
CY2024Q2 us-gaap Liabilities
Liabilities
10000700000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
9444500000 usd
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
30000000 shares
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
30000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
25150700000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
23137900000 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
35151400000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
32582400000 usd
CY2024Q2 us-gaap Revenues
Revenues
9965700000 usd
CY2023Q2 us-gaap Revenues
Revenues
9725600000 usd
us-gaap Revenues
Revenues
26798800000 usd
us-gaap Revenues
Revenues
24956400000 usd
CY2024Q2 us-gaap Cost Of Revenue
CostOfRevenue
7323700000 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
7141800000 usd
us-gaap Cost Of Revenue
CostOfRevenue
19817700000 usd
us-gaap Cost Of Revenue
CostOfRevenue
18429300000 usd
CY2024Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
923600000 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
852100000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2639200000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2362600000 usd
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
80600000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
52200000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
233100000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
131900000 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1799000000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1783900000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4575000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4296400000 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
432200000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
432200000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1068800000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1026700000 usd
CY2024Q2 us-gaap Profit Loss
ProfitLoss
1366800000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
1351700000 usd
us-gaap Profit Loss
ProfitLoss
3506200000 usd
us-gaap Profit Loss
ProfitLoss
3269700000 usd
CY2024Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
13200000 usd
CY2023Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
16600000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
33200000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
33700000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
1353600000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
1335100000 usd
us-gaap Net Income Loss
NetIncomeLoss
3473000000 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.12
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.93
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
328400000 shares
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
23137900000 usd
CY2023Q4 us-gaap Profit Loss
ProfitLoss
955700000 usd
CY2023Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1600000 usd
CY2023Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3100000 usd
CY2023Q4 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
37500000 usd
CY2023Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
40900000 usd
CY2023Q4 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
99900000 usd
CY2023Q4 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
398300000 usd
CY2023Q4 us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Issuance Of Equity By Subsidiary To Noncontrolling Interests
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesIssuanceOfEquityBySubsidiaryToNoncontrollingInterests
0 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
1183700000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3600000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
6900000 usd
CY2024Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
44100000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
25000000.0 usd
CY2024Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
99200000 usd
CY2024Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
402200000 usd
CY2023Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
493400000 usd
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
333000000.0 shares
CY2024Q2 us-gaap Profit Loss
ProfitLoss
1366800000 usd
CY2023Q1 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
271700000 usd
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3020000000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3900100000 usd
CY2023Q3 us-gaap Inventory Homes Under Construction
InventoryHomesUnderConstruction
9001400000 usd
CY2024Q2 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
12413400000 usd
CY2023Q3 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
10621900000 usd
CY2024Q2 us-gaap Inventory Land Held For Development And Sale
InventoryLandHeldForDevelopmentAndSale
155800000 usd
CY2023Q3 us-gaap Inventory Land Held For Development And Sale
InventoryLandHeldForDevelopmentAndSale
50000000.0 usd
CY2023Q3 us-gaap Inventory Operative Builders Other
InventoryOperativeBuildersOther
2691300000 usd
CY2024Q2 us-gaap Inventory Real Estate
InventoryRealEstate
25536100000 usd
CY2024Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
75398026 shares
CY2023Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
66353688 shares
CY2024Q2 us-gaap Treasury Stock Value
TreasuryStockValue
5571700000 usd
CY2023Q3 us-gaap Treasury Stock Value
TreasuryStockValue
4329800000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
24656500000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
22696200000 usd
CY2024Q2 us-gaap Minority Interest
MinorityInterest
494200000 usd
CY2023Q3 us-gaap Minority Interest
MinorityInterest
441700000 usd
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
9.39
CY2024Q1 us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Issuance Of Equity By Subsidiary To Noncontrolling Interests
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesIssuanceOfEquityBySubsidiaryToNoncontrollingInterests
19200000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
24296400000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
949600000 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#OtherAssets
CY2023Q3 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#OtherAssets
CY2024Q2 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#OtherLiabilities
CY2023Q3 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#OtherLiabilities
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
D.R. Horton, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
75-2386963
dei Entity Address Address Line1
EntityAddressAddressLine1
1341 Horton Circle
dei Entity Address City Or Town
EntityAddressCityOrTown
Arlington
dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
76011
dei City Area Code
CityAreaCode
817
dei Local Phone Number
LocalPhoneNumber
390-8200
dei Security12b Title
Security12bTitle
Common Stock, par value $.01 per share
dei Trading Symbol
TradingSymbol
DHI
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
326040096 shares
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2992300000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3873600000 usd
CY2024Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
27700000 usd
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
26500000 usd
CY2024Q2 us-gaap Inventory Homes Under Construction
InventoryHomesUnderConstruction
9880500000 usd
CY2024Q2 us-gaap Inventory Land Held For Sale
InventoryLandHeldForSale
15800000 usd
CY2023Q3 us-gaap Inventory Land Held For Sale
InventoryLandHeldForSale
8700000 usd
CY2024Q2 us-gaap Inventory Operative Builders Other
InventoryOperativeBuildersOther
3070600000 usd
CY2023Q3 us-gaap Inventory Real Estate
InventoryRealEstate
22373300000 usd
CY2024Q2 us-gaap Loans Receivable Held For Sale Net Not Part Of Disposal Group
LoansReceivableHeldForSaleNetNotPartOfDisposalGroup
2578800000 usd
CY2023Q3 us-gaap Loans Receivable Held For Sale Net Not Part Of Disposal Group
LoansReceivableHeldForSaleNetNotPartOfDisposalGroup
2519900000 usd
CY2024Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
14700000 usd
CY2023Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
14800000 usd
CY2024Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
156600000 usd
CY2023Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
187200000 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
520900000 usd
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
402771463 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
327373437 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
401202253 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
334848565 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
4000000.0 usd
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
4000000.0 usd
CY2024Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
3458900000 usd
CY2023Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
3432200000 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
26765300000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
23589800000 usd
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
344700000 shares
CY2024Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1900000 usd
CY2024Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1300000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
26800000 usd
CY2024Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
98500000 usd
CY2024Q2 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
441400000 usd
CY2024Q2 us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Issuance Of Equity By Subsidiary To Noncontrolling Interests
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesIssuanceOfEquityBySubsidiaryToNoncontrollingInterests
0 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
25150700000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
19785600000 usd
CY2022Q4 us-gaap Profit Loss
ProfitLoss
968300000 usd
CY2022Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2600000 usd
CY2022Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2900000 usd
CY2022Q4 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
25700000 usd
CY2022Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
22900000 usd
CY2022Q4 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
86100000 usd
CY2022Q4 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
118100000 usd
CY2022Q4 us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Issuance Of Equity By Subsidiary To Noncontrolling Interests
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesIssuanceOfEquityBySubsidiaryToNoncontrollingInterests
0 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
20552400000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5600000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4700000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
28400000 usd
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
85600000 usd
CY2023Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
303200000 usd
CY2023Q1 us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Issuance Of Equity By Subsidiary To Noncontrolling Interests
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesIssuanceOfEquityBySubsidiaryToNoncontrollingInterests
0 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
21121800000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
1351700000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5700000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2000000.0 usd
CY2023Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
100000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
29300000 usd
CY2023Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
85200000 usd
CY2023Q2 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
342900000 usd
CY2023Q2 us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Issuance Of Equity By Subsidiary To Noncontrolling Interests
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesIssuanceOfEquityBySubsidiaryToNoncontrollingInterests
0 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
22082300000 usd
us-gaap Profit Loss
ProfitLoss
3506200000 usd
us-gaap Profit Loss
ProfitLoss
3269700000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
63500000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
70200000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
92700000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
80600000 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-29900000 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-19300000 usd
us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
34400000 usd
us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
62200000 usd
us-gaap Increase Decrease In Finished Goods And Work In Process Inventories
IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories
863000000.0 usd
us-gaap Increase Decrease In Finished Goods And Work In Process Inventories
IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories
-576200000 usd
us-gaap Increase Decrease In Inventory For Long Term Contracts Or Programs
IncreaseDecreaseInInventoryForLongTermContractsOrPrograms
2012100000 usd
us-gaap Increase Decrease In Inventory For Long Term Contracts Or Programs
IncreaseDecreaseInInventoryForLongTermContractsOrPrograms
915000000.0 usd
dhi Increase Decrease In Rental Properties
IncreaseDecreaseInRentalProperties
375700000 usd
dhi Increase Decrease In Rental Properties
IncreaseDecreaseInRentalProperties
777300000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
154400000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-242100000 usd
us-gaap Increase Decrease In Mortgage Loans Held For Sale
IncreaseDecreaseInMortgageLoansHeldForSale
58900000 usd
us-gaap Increase Decrease In Mortgage Loans Held For Sale
IncreaseDecreaseInMortgageLoansHeldForSale
28400000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-34400000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-338500000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
228200000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2261100000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
133300000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
108300000 usd
us-gaap Proceeds From Sale Of Buildings
ProceedsFromSaleOfBuildings
14900000 usd
us-gaap Proceeds From Sale Of Buildings
ProceedsFromSaleOfBuildings
0 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
37900000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
202000000.0 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
4800000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-1800000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-161100000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-308500000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
1270000000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
575000000.0 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
640400000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
675400000 usd
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
21800000 usd
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
67300000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
12200000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
18700000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
82900000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
55900000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
297500000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
256900000 usd
us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
1230300000 usd
us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
759600000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
19700000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-19800000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-30700000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-947200000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1117500000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-880100000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
835100000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3900100000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2572900000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3020000000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3408000000 usd
us-gaap Notes Issued1
NotesIssued1
43400000 usd
us-gaap Notes Issued1
NotesIssued1
54500000 usd
us-gaap Notes Reduction
NotesReduction
127800000 usd
us-gaap Notes Reduction
NotesReduction
0 usd
us-gaap Stock Issued1
StockIssued1
173200000 usd
us-gaap Stock Issued1
StockIssued1
110800000 usd
dhi Repurchase Of Common Stock Not Settled
RepurchaseOfCommonStockNotSettled
1500000 usd
dhi Repurchase Of Common Stock Not Settled
RepurchaseOfCommonStockNotSettled
0 usd
us-gaap Use Of Estimates
UseOfEstimates
<div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates.</span></div>
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2992300000 usd
CY2024Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
27700000 usd
CY2024Q2 us-gaap Inventory Homes Under Construction
InventoryHomesUnderConstruction
9880500000 usd
CY2024Q2 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
12413400000 usd
CY2024Q2 us-gaap Inventory Land Held For Development And Sale
InventoryLandHeldForDevelopmentAndSale
155800000 usd
CY2024Q2 us-gaap Inventory Land Held For Sale
InventoryLandHeldForSale
15800000 usd
CY2024Q2 us-gaap Inventory Operative Builders Other
InventoryOperativeBuildersOther
3070600000 usd
CY2024Q2 us-gaap Inventory Real Estate
InventoryRealEstate
25536100000 usd
CY2024Q2 us-gaap Loans Receivable Held For Sale Net Not Part Of Disposal Group
LoansReceivableHeldForSaleNetNotPartOfDisposalGroup
2578800000 usd
CY2024Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
156600000 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
520900000 usd
CY2024Q2 us-gaap Other Assets
OtherAssets
3175500000 usd
CY2024Q2 us-gaap Goodwill
Goodwill
163500000 usd
CY2024Q2 us-gaap Assets
Assets
35151400000 usd
CY2024Q2 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
1412700000 usd
CY2024Q2 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
2897000000 usd
CY2024Q2 us-gaap Notes Payable
NotesPayable
5691000000 usd
CY2024Q2 us-gaap Liabilities
Liabilities
10000700000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3873600000 usd
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
26500000 usd
CY2023Q3 us-gaap Inventory Homes Under Construction
InventoryHomesUnderConstruction
9001400000 usd
CY2023Q3 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
10621900000 usd
CY2023Q3 us-gaap Inventory Land Held For Development And Sale
InventoryLandHeldForDevelopmentAndSale
50000000.0 usd
CY2023Q3 us-gaap Inventory Land Held For Sale
InventoryLandHeldForSale
8700000 usd
CY2023Q3 us-gaap Inventory Operative Builders Other
InventoryOperativeBuildersOther
2691300000 usd
CY2023Q3 us-gaap Inventory Real Estate
InventoryRealEstate
22373300000 usd
CY2023Q3 us-gaap Loans Receivable Held For Sale Net Not Part Of Disposal Group
LoansReceivableHeldForSaleNetNotPartOfDisposalGroup
2519900000 usd
CY2023Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
187200000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
445400000 usd
CY2023Q3 us-gaap Other Assets
OtherAssets
2993000000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
163500000 usd
CY2023Q3 us-gaap Assets
Assets
32582400000 usd
CY2023Q3 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
1246200000 usd
CY2023Q3 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
3103800000 usd
CY2023Q3 us-gaap Notes Payable
NotesPayable
5094500000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
9444500000 usd
CY2024Q2 us-gaap Revenues
Revenues
9965700000 usd
CY2024Q2 us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
14800000 usd
CY2024Q2 us-gaap Cost Of Revenue
CostOfRevenue
7323700000 usd
CY2024Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
923600000 usd
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
80600000 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1799000000 usd
us-gaap Revenues
Revenues
26798800000 usd
us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
34400000 usd
us-gaap Cost Of Revenue
CostOfRevenue
19817700000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2639200000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
233100000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4575000000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
63500000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
228200000 usd
CY2023Q2 us-gaap Revenues
Revenues
9725600000 usd
CY2023Q2 us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
10800000 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
7141800000 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
852100000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
52200000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1783900000 usd
us-gaap Revenues
Revenues
24956400000 usd
us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
62200000 usd
us-gaap Cost Of Revenue
CostOfRevenue
18429300000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2362600000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
131900000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4296400000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
70200000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2261100000 usd
CY2024Q2 us-gaap Inventory Write Down
InventoryWriteDown
0 usd
us-gaap Inventory Write Down
InventoryWriteDown
5600000 usd
CY2023Q2 us-gaap Inventory Write Down
InventoryWriteDown
0 usd
us-gaap Inventory Write Down
InventoryWriteDown
14000000.0 usd
CY2024Q2 us-gaap Loss On Contract Termination
LossOnContractTermination
14800000 usd
us-gaap Loss On Contract Termination
LossOnContractTermination
28800000 usd
CY2023Q2 us-gaap Loss On Contract Termination
LossOnContractTermination
10800000 usd
us-gaap Loss On Contract Termination
LossOnContractTermination
48200000 usd
CY2024Q2 us-gaap Notes Payable
NotesPayable
5691000000 usd
CY2023Q3 us-gaap Notes Payable
NotesPayable
5094500000 usd
CY2024Q1 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
318700000 usd
CY2023Q3 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
286400000 usd
CY2022Q3 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
237400000 usd
CY2024Q2 us-gaap Interest Costs Incurred
InterestCostsIncurred
54500000 usd
CY2023Q2 us-gaap Interest Costs Incurred
InterestCostsIncurred
57400000 usd
us-gaap Interest Costs Incurred
InterestCostsIncurred
147600000 usd
us-gaap Interest Costs Incurred
InterestCostsIncurred
154200000 usd
CY2024Q2 us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
35300000 usd
CY2023Q2 us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
41300000 usd
us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
96100000 usd
us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
103800000 usd
CY2024Q2 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
337900000 usd
CY2023Q2 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
287800000 usd
CY2024Q2 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
337900000 usd
CY2023Q2 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
287800000 usd
CY2024Q2 us-gaap Loans Receivable Held For Sale Net Not Part Of Disposal Group
LoansReceivableHeldForSaleNetNotPartOfDisposalGroup
2600000000 usd
CY2024Q2 us-gaap Principal Amount Outstanding On Loans Held For Sale Or Securitization
PrincipalAmountOutstandingOnLoansHeldForSaleOrSecuritization
2600000000 usd
CY2023Q3 us-gaap Loans Receivable Held For Sale Net Not Part Of Disposal Group
LoansReceivableHeldForSaleNetNotPartOfDisposalGroup
2500000000 usd
CY2023Q3 us-gaap Principal Amount Outstanding On Loans Held For Sale Or Securitization
PrincipalAmountOutstandingOnLoansHeldForSaleOrSecuritization
2600000000 usd
us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
17700000000 usd
us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
15300000000 usd
us-gaap Proceeds From Sale Of Mortgage Loans Held For Sale
ProceedsFromSaleOfMortgageLoansHeldForSale
17700000000 usd
us-gaap Proceeds From Sale Of Mortgage Loans Held For Sale
ProceedsFromSaleOfMortgageLoansHeldForSale
15300000000 usd
CY2024Q2 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
162600000 usd
us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
444000000.0 usd
CY2023Q2 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
157900000 usd
us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
391600000 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
432200000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
432200000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1100000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1000000000.0 usd
CY2024Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.240
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.234
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.242
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.239
CY2024Q2 dhi Deferred Tax Assets Net Of Deferred Tax Liabilities
DeferredTaxAssetsNetOfDeferredTaxLiabilities
171300000 usd
CY2023Q3 dhi Deferred Tax Assets Net Of Deferred Tax Liabilities
DeferredTaxAssetsNetOfDeferredTaxLiabilities
202000000.0 usd
CY2024Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
14700000 usd
CY2023Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
14800000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
1353600000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
1335100000 usd
us-gaap Net Income Loss
NetIncomeLoss
3473000000 usd
us-gaap Net Income Loss
NetIncomeLoss
3236000000 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
328400000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
339900000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
330900000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
342100000 shares
CY2024Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1700000 shares
CY2023Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2400000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2100000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2600000 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
330100000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
342300000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
333000000.0 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
344700000 shares
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.12
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.93
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
10.50
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
9.46
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.10
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.90
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
10.43
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
9.39
CY2024Q2 srt Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
1500000000 usd
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
9000000.0 shares
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1200000000 usd
CY2023Q4 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
201600000 usd
CY2024Q2 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
459700000 usd
CY2024Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.30
CY2024Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.30
CY2024Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.30
CY2023Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.30
CY2023Q4 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.30
CY2024Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.30
CY2024Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
544600000 usd
CY2023Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
474700000 usd
CY2023Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
512400000 usd
CY2022Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
454300000 usd
CY2024Q2 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
58100000 usd
CY2023Q2 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
52600000 usd
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
156600000 usd
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
136500000 usd
CY2024Q2 us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
-4900000 usd
CY2023Q2 us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
-1700000 usd
us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
-12500000 usd
us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
-4500000 usd
CY2024Q2 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
30200000 usd
CY2023Q2 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
32200000 usd
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
88900000 usd
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
92900000 usd
CY2024Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
567600000 usd
CY2024Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
567600000 usd
CY2023Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
493400000 usd
CY2024Q2 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
911100000 usd
CY2023Q3 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
858900000 usd
CY2023Q3 dhi Construction Defect Portion Of Loss Contingency Accrual
ConstructionDefectPortionOfLossContingencyAccrual
0.97
CY2024Q2 dhi Construction Defect Portion Of Loss Contingency Accrual
ConstructionDefectPortionOfLossContingencyAccrual
0.97
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
107900000 usd
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
92600000 usd
CY2023Q3 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
858900000 usd
CY2022Q3 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
729100000 usd
us-gaap Loss Contingency Accrual Carrying Value Period Increase Decrease
LossContingencyAccrualCarryingValuePeriodIncreaseDecrease
112100000 usd
us-gaap Loss Contingency Accrual Carrying Value Period Increase Decrease
LossContingencyAccrualCarryingValuePeriodIncreaseDecrease
101800000 usd
us-gaap Loss Contingency Accrual Payments
LossContingencyAccrualPayments
59900000 usd
us-gaap Loss Contingency Accrual Payments
LossContingencyAccrualPayments
34700000 usd
CY2024Q2 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
911100000 usd
CY2023Q2 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
796200000 usd
CY2024Q2 us-gaap Insurance Settlements Receivable
InsuranceSettlementsReceivable
158600000 usd
CY2023Q3 us-gaap Insurance Settlements Receivable
InsuranceSettlementsReceivable
165800000 usd
CY2023Q2 us-gaap Insurance Settlements Receivable
InsuranceSettlementsReceivable
139000000.0 usd
CY2024Q2 us-gaap Earnest Money Deposits
EarnestMoneyDeposits
2100000000 usd
CY2024Q2 us-gaap Purchase Obligation
PurchaseObligation
24500000000 usd
CY2024Q2 us-gaap Special Assessment Bond Noncurrent
SpecialAssessmentBondNoncurrent
3400000000 usd
CY2024Q2 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
242100000 usd
CY2024Q2 us-gaap Deposits Assets
DepositsAssets
2108500000 usd
CY2023Q3 us-gaap Deposits Assets
DepositsAssets
1859600000 usd
CY2024Q2 us-gaap Derivative Instruments Not Designated As Hedging Instruments Asset At Fair Value
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue
10100000 usd
CY2023Q3 us-gaap Derivative Instruments Not Designated As Hedging Instruments Asset At Fair Value
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue
153600000 usd
CY2024Q2 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
320900000 usd
CY2023Q3 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
319600000 usd
CY2024Q2 us-gaap Margin Deposit Assets
MarginDepositAssets
36800000 usd
CY2023Q3 us-gaap Margin Deposit Assets
MarginDepositAssets
0 usd
CY2024Q2 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
161500000 usd
CY2023Q3 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
167200000 usd
CY2024Q2 us-gaap Insurance Settlements Receivable
InsuranceSettlementsReceivable
158600000 usd
CY2023Q3 us-gaap Insurance Settlements Receivable
InsuranceSettlementsReceivable
165800000 usd
CY2024Q2 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
96300000 usd
CY2023Q3 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
93000000.0 usd
CY2024Q2 dhi Contract Asset Insurance Renewals
ContractAssetInsuranceRenewals
110900000 usd
CY2023Q3 dhi Contract Asset Insurance Renewals
ContractAssetInsuranceRenewals
93900000 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
50400000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
46600000 usd
CY2024Q2 us-gaap Servicing Asset
ServicingAsset
5000000.0 usd
CY2023Q3 us-gaap Servicing Asset
ServicingAsset
11100000 usd
CY2024Q2 us-gaap Other Assets Miscellaneous
OtherAssetsMiscellaneous
76600000 usd
CY2023Q3 us-gaap Other Assets Miscellaneous
OtherAssetsMiscellaneous
80300000 usd
CY2024Q2 us-gaap Other Assets
OtherAssets
3175500000 usd
CY2023Q3 us-gaap Other Assets
OtherAssets
2993000000 usd
CY2024Q2 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
911100000 usd
CY2023Q3 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
858900000 usd
CY2024Q2 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
525300000 usd
CY2023Q3 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
531000000.0 usd
CY2024Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
567600000 usd
CY2023Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
512400000 usd
CY2024Q2 us-gaap Construction Payable Current And Noncurrent
ConstructionPayableCurrentAndNoncurrent
403900000 usd
CY2023Q3 us-gaap Construction Payable Current And Noncurrent
ConstructionPayableCurrentAndNoncurrent
353600000 usd
CY2024Q2 us-gaap Other Payables To Broker Dealers And Clearing Organizations
OtherPayablesToBrokerDealersAndClearingOrganizations
0 usd
CY2023Q3 us-gaap Other Payables To Broker Dealers And Clearing Organizations
OtherPayablesToBrokerDealersAndClearingOrganizations
118900000 usd
CY2024Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
136800000 usd
CY2023Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
147100000 usd
CY2024Q2 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
64200000 usd
CY2023Q3 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
233800000 usd
CY2024Q2 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
56200000 usd
CY2023Q3 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
69200000 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
51200000 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
48100000 usd
CY2024Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
21400000 usd
CY2023Q3 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
33600000 usd
CY2024Q2 us-gaap Other Derivatives Not Designated As Hedging Instruments Liabilities At Fair Value
OtherDerivativesNotDesignatedAsHedgingInstrumentsLiabilitiesAtFairValue
20500000 usd
CY2023Q3 us-gaap Other Derivatives Not Designated As Hedging Instruments Liabilities At Fair Value
OtherDerivativesNotDesignatedAsHedgingInstrumentsLiabilitiesAtFairValue
15700000 usd
CY2024Q2 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
138700000 usd
CY2023Q3 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
147600000 usd
CY2024Q2 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
2897000000 usd
CY2023Q3 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
3103800000 usd
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false

Files In Submission

Name View Source Status
0000882184-24-000039-index-headers.html Edgar Link pending
0000882184-24-000039-index.html Edgar Link pending
0000882184-24-000039.txt Edgar Link pending
0000882184-24-000039-xbrl.zip Edgar Link pending
a6302024exhibit221.htm Edgar Link pending
a6302024exhibit311.htm Edgar Link pending
a6302024exhibit312.htm Edgar Link pending
a6302024exhibit321.htm Edgar Link pending
a6302024exhibit322.htm Edgar Link pending
dhi-20240630.htm Edgar Link pending
dhi-20240630.xsd Edgar Link pending
dhi-20240630_g1.jpg Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
dhi-20240630_cal.xml Edgar Link unprocessable
dhi-20240630_htm.xml Edgar Link completed
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
dhi-20240630_def.xml Edgar Link unprocessable
dhi-20240630_lab.xml Edgar Link unprocessable
dhi-20240630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable